Olga Balafa

2.3k total citations
40 papers, 604 citations indexed

About

Olga Balafa is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olga Balafa has authored 40 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Nephrology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olga Balafa's work include Dialysis and Renal Disease Management (18 papers), Blood Pressure and Hypertension Studies (6 papers) and Central Venous Catheters and Hemodialysis (6 papers). Olga Balafa is often cited by papers focused on Dialysis and Renal Disease Management (18 papers), Blood Pressure and Hypertension Studies (6 papers) and Central Venous Catheters and Hemodialysis (6 papers). Olga Balafa collaborates with scholars based in Greece, United States and Italy. Olga Balafa's co-authors include Raymond T. Krediet, Rigas Kalaitzidis, Pantelis Sarafidis, Kostas C. Siamopoulos, Nynke Halbesma, Friedo W. Dekker, Dirk G. Struijk, Charles J. Ferro, Maria Eleni Alexandrou and Francesca Mallamaci and has published in prestigious journals such as Drugs, Clinical Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Olga Balafa

39 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Balafa Greece 13 343 152 117 111 108 40 604
Gabriela Cobo Spain 11 439 1.3× 76 0.5× 156 1.3× 67 0.6× 94 0.9× 17 762
Enrique Rojas–Campos Mexico 14 347 1.0× 88 0.6× 72 0.6× 64 0.6× 65 0.6× 57 616
Marcela Ávila–Díaz Mexico 12 315 0.9× 86 0.6× 95 0.8× 71 0.6× 74 0.7× 20 503
Julia Lewis United States 11 614 1.8× 208 1.4× 131 1.1× 97 0.9× 130 1.2× 13 913
Jonathan J. Taliercio United States 12 219 0.6× 59 0.4× 103 0.9× 85 0.8× 93 0.9× 46 526
Michael P. Delaney United Kingdom 14 431 1.3× 121 0.8× 83 0.7× 40 0.4× 91 0.8× 24 686
Chang-Yun Yoon South Korea 13 271 0.8× 98 0.6× 59 0.5× 48 0.4× 69 0.6× 27 548
Yi-Wen Chiu Taiwan 11 654 1.9× 98 0.6× 121 1.0× 55 0.5× 125 1.2× 17 902
Mihály Tapolyai United States 14 472 1.4× 85 0.6× 169 1.4× 33 0.3× 113 1.0× 48 663
Tej K. Mattoo United States 16 153 0.4× 198 1.3× 119 1.0× 62 0.6× 113 1.0× 33 561

Countries citing papers authored by Olga Balafa

Since Specialization
Citations

This map shows the geographic impact of Olga Balafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Balafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Balafa more than expected).

Fields of papers citing papers by Olga Balafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Balafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Balafa. The network helps show where Olga Balafa may publish in the future.

Co-authorship network of co-authors of Olga Balafa

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Balafa. A scholar is included among the top collaborators of Olga Balafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Balafa. Olga Balafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petrakis, Ioannis, Olga Balafa, Evangelia Dounousi, et al.. (2024). Cardiovascular and All-Cause Mortality Is Affected by Serum Magnesium and Diet Pattern in a Cohort of Dialysis Patients. Journal of Clinical Medicine. 13(14). 4024–4024. 2 indexed citations
2.
Balafa, Olga, Beatriz Fernández‐Fernández, Alberto Ortíz, et al.. (2024). Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clinical Kidney Journal. 17(3). 17 indexed citations
3.
Vecchio, Lucia Del, Olga Balafa, Evangelia Dounousi, et al.. (2023). COVID-19 and cardiovascular disease in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 39(2). 177–189. 9 indexed citations
4.
Mark, Patrick B., Pantelis Sarafidis, Robert Ekart, et al.. (2023). SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA. Nephrology Dialysis Transplantation. 38(11). 2444–2455. 35 indexed citations
5.
Petrakis, Ioannis, et al.. (2022). Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease. Journal of Clinical Medicine. 11(19). 5746–5746. 5 indexed citations
6.
Balafa, Olga, et al.. (2022). Lower serum magnesium is a predictor of left ventricular hypertrophy in patients on dialysis. International Urology and Nephrology. 55(4). 1015–1023.
7.
Valdivielso, José Manuel, Olga Balafa, Robert Ekart, et al.. (2021). Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies. Drugs. 81(13). 1467–1489. 30 indexed citations
8.
Balafa, Olga & Rigas Kalaitzidis. (2020). Salt sensitivity and hypertension. Journal of Human Hypertension. 35(3). 184–192. 60 indexed citations
9.
Alexandrou, Maria Eleni, Olga Balafa, & Pantelis Sarafidis. (2020). Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques. American Journal of Nephrology. 51(8). 589–612. 27 indexed citations
10.
Balafa, Olga, et al.. (2018). Nodular glomerulosclerosis: not always diabetic nephropathy. Minerva Medica. 109(3). 248–250. 1 indexed citations
11.
Kalaitzidis, Rigas, et al.. (2017). Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. International Urology and Nephrology. 49(8). 1401–1407. 27 indexed citations
12.
Balafa, Olga, et al.. (2016). Chlorhexidine for routine PD catheter exit-site care. International Urology and Nephrology. 48(9). 1543–1546. 3 indexed citations
13.
Balafa, Olga, et al.. (2016). “Diabetic nephropathy” in a non-diabetic patient. Pathology - Research and Practice. 212(12). 1199–1201. 2 indexed citations
14.
Katopodis, K., et al.. (2015). Estimation of Residual Peritoneal Volume Using Technetium-99m Sulfur Colloid Scintigraphy. ASAIO Journal. 61(4). 459–462. 1 indexed citations
15.
Balafa, Olga, Rigas Kalaitzidis, & Kostas C. Siamopoulos. (2013). Optimal Medical Management in Patients with Renovascular Hypertension. American Journal of Cardiovascular Drugs. 13(2). 71–78. 13 indexed citations
16.
Balafa, Olga, et al.. (2013). Posterior Reversible Encephalopathy Syndrome: A Noteworthy Syndrome in End-Stage Renal Disease Patients. Nephron Clinical Practice. 123(3-4). 180–184. 9 indexed citations
17.
Kalaitzidis, Rigas, et al.. (2013). Risk factors for cognitive dysfunction in CKD and hypertensive subjects. International Urology and Nephrology. 45(6). 1637–1646. 26 indexed citations
18.
Krediet, Raymond T. & Olga Balafa. (2010). Cardiovascular risk in the peritoneal dialysis patient. Nature Reviews Nephrology. 6(8). 451–460. 124 indexed citations
19.
Balafa, Olga, Nynke Halbesma, Dirk G. Struijk, Friedo W. Dekker, & Raymond T. Krediet. (2010). Peritoneal Albumin and Protein Losses Do Not Predict Outcome in Peritoneal Dialysis Patients. Clinical Journal of the American Society of Nephrology. 6(3). 561–566. 59 indexed citations
20.
Tseke, Paraskevi, et al.. (2009). Epidemiology of Acute Renal Failure in ICUs: A Multi-Center Prospective Study. Blood Purification. 28(3). 239–244. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026